Neuroimaging Platform

Contents

logo_neurinfo

The NEURINFO platform. Neurinfo is a technical platform offering imaging resources for developing and promoting methodological and technological clinical research. This platform involves human in vivo imaging and neuro-computing particularly in the context of nervous system diseases. It is open to a broad community of medical and scientific users, regionally, nationally, and internationally. Since 2009, Neurinfo has been equipped with a 3T MRI installed at the Rennes University Hospital. A team of engineers assists users in their clinical and/or methodology research projects.

  • You can click on the image to visite the Neurinfo website for more details, also regarding publishing data acquired at Neurinfo and the corresponding acknowledgments that you should mention in your communication (see below for details).

neurinfo1

We have an IRB approval to perform protocol and sequence optimisation studies at Neurinfo. If you have benefited from this IRB approval for proof-of-concept studies, please cite it in your M&M section so that we can track the studies performed using this protocol.

If data was acquired on healthy controls before October 2021, please cite the OSS-IRM protocol :

“After approval from the Institutional Review Board, the volunteers were included in the OSS IRM (https://clinicaltrials.gov/ct2/show/NCT03440983) study, supported by the University Hospital of Rennes and the University of Rennes. ”

If data was acquired on patients, please cite the relevant IRB approval

For data acquired after October 2021, in healthy controls and possibly also for some patients studies, please cite the OSV-IRM protocol (https://clinicaltrials.gov/ct2/show/NCT05107232). This protocol also asks the volunteers if they agree to share data beyond the study itself. Check with Neurinfo staff for details.

We can share data, provided that we have the subjects consent (OBC) for data re-use and a Data User Agreement (DUA) transfering processing responsability and duties (do not try to identify the subject, do not share the data further). For more details, you can check the following references :

HBM 2020 paper – co-authored by members of the team and the DPO from the University Hospital.

Github link and link to the Open Brain Consent Initiative webpage with  consent form and DUA samples in different languages among which french

————

Also the Neurinfo facility funding sources need to be acknowlegded in the acknowledgment section, together with the project grant :

If data was acquired on the Verio scanner  (between 2009 and Feb 2018) : MRI data acquisition was supported by the Neurinfo MRI research facility from the University of Rennes I. Neurinfo is granted by the the European Union (FEDER), the French State, the Brittany Council, Rennes Metropole, Inria, Inserm and the University Hospital of Rennes.

System description : Magnetom Verio VB17 (Siemens Healthineers, Erlangen, Germany), 12 or 32 ch head coil most probably

If data was acquired on the Prisma scanner (after Feb 2018)  : MRI data acquisition was performed at the Neurinfo MRI research facility from the University of Rennes I, University Hospital of Rennes, Inria, CNRS and the Rennes Cancer Center. Neurinfo is also supported by the the Brittany Council, Rennes Metropole and GIS IBISA

System description : Magnetom Prisma VE11C (Siemens Healthineers, Erlangen, Germany), 20 or 64 ch head coil most probably

En français : Les acquisitions IRM ont été réalisées sur Neurinfo, plateforme de l’Université de Rennes 1, du CHU de Rennes, d’Inria, du CNRS et du CRLCC. Neurinfo est également soutenue par la Région Bretagne, Rennes Métropole et le GIS IBISA.

If data was acquired on both scanners : MRI data acquisition was supported by the Neurinfo MRI research facility from the University of Rennes I, University Hospital of Rennes, Inria, CNRS and the Rennes Cancer Center. Neurinfo was also supported by the European Research Council (FEDER), the French State, the Brittany Council, Rennes Metropole, Inserm and GIS IBISA

Comments are closed.